- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.97 Å
- Oligo State
- monomer
- Ligands
- 1 x R4P: 1-methyl-5-(2'-methyl[1,1'-biphenyl]-4-yl)-1H-benzotriazole-7-carboxylic acid(Non-covalent)
- 2 x DET: UNDECYLAMINE-N,N-DIMETHYL-N-OXIDE(Non-covalent)
DET.2: 11 residues within 4Å:- Chain A: H.28, R.29, K.72, H.73, P.97, Q.98, E.99, N.122, S.123, H.124
- Ligands: NA.7
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:P.97, A:E.99, A:N.122
- Hydrogen bonds: A:R.29, A:Y.119
DET.3: 6 residues within 4Å:- Chain A: E.111, D.112, Q.113, P.262, K.279, P.280
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:Q.113
- Water bridges: A:A.263
- 2 x DDQ: DECYLAMINE-N,N-DIMETHYL-N-OXIDE(Non-covalent)
DDQ.4: 8 residues within 4Å:- Chain A: Y.10, L.14, L.18, F.34, L.39, L.40, P.41
- Ligands: R4P.1
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:L.14, A:L.18, A:F.34, A:F.34
- Hydrogen bonds: A:L.40
DDQ.5: 4 residues within 4Å:- Chain A: R.319, Q.353, F.355, A.364
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:Q.353, A:F.355
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- 3 x NA: SODIUM ION(Non-functional Binders)
NA.7: 5 residues within 4Å:- Chain A: E.25, R.29, R.103, R.105
- Ligands: DET.2
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:R.29, A:R.29, A:R.105
NA.8: 2 residues within 4Å:- Chain A: S.234, E.238
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:S.234, A:E.238
NA.9: 5 residues within 4Å:- Chain A: K.199, R.203, S.242, V.243, E.246
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:K.199, A:R.203, A:R.203, A:E.246
- 1 x FMN: FLAVIN MONONUCLEOTIDE(Non-covalent)
FMN.10: 24 residues within 4Å:- Chain A: A.67, A.68, G.69, K.72, G.91, S.92, N.117, Y.119, N.153, N.184, K.227, T.255, N.256, T.257, S.277, G.278, L.281, V.305, G.306, G.307, L.327, Y.328, T.329
- Ligands: ORO.11
23 PLIP interactions:23 interactions with chain A- Hydrophobic interactions: A:N.117, A:Y.119, A:Y.328, A:Y.328
- Hydrogen bonds: A:A.68, A:K.72, A:S.92, A:S.92, A:N.153, A:N.184, A:K.227, A:K.227, A:N.256, A:S.277, A:S.277, A:G.278, A:G.307, A:Y.328, A:T.329, A:T.329
- Water bridges: A:A.68, A:G.306, A:G.306
- 1 x ORO: OROTIC ACID(Non-covalent)
ORO.11: 13 residues within 4Å:- Chain A: K.72, N.117, R.118, Y.119, G.120, F.121, N.184, S.187, P.188, N.189, N.256, T.257
- Ligands: FMN.10
13 PLIP interactions:13 interactions with chain A- Hydrophobic interactions: A:F.121
- Hydrogen bonds: A:N.117, A:N.117, A:N.117, A:G.120, A:F.121, A:N.184, A:N.189, A:N.256, A:N.256
- Water bridges: A:S.187, A:S.187
- Salt bridges: A:K.72
- 3 x ACT: ACETATE ION(Non-functional Binders)
ACT.12: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)ACT.13: 4 residues within 4Å:- Chain A: K.199, E.238, D.239, S.242
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:K.199
ACT.14: 2 residues within 4Å:- Chain A: R.213, R.221
2 PLIP interactions:2 interactions with chain A- Water bridges: A:R.221
- Salt bridges: A:R.213
- 6 x GOL: GLYCEROL(Non-functional Binders)
GOL.15: 3 residues within 4Å:- Chain A: D.78, Y.81, L.143
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:D.78
GOL.16: 4 residues within 4Å:- Chain A: P.102, R.103, P.104, R.118
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:P.102, A:R.103, A:R.118
GOL.17: 7 residues within 4Å:- Chain A: Q.137, Q.140, A.141, T.144, L.177, A.178, D.179
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:Q.137, A:A.141, A:T.144, A:T.144, A:D.179
GOL.18: 2 residues within 4Å:- Chain A: R.29, L.30
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:R.29
GOL.19: 4 residues within 4Å:- Chain A: Y.293, A.294, Q.297, H.366
2 PLIP interactions:2 interactions with chain A- Water bridges: A:G.363, A:H.366
GOL.20: 2 residues within 4Å:- Chain A: G.20, L.21
No protein-ligand interaction detected (PLIP)- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- McDonald, G. et al., Selective Vulnerability to Pyrimidine Starvation in Hematologic Malignancies Revealed by AG-636, a Novel Clinical-Stage Inhibitor of Dihydroorotate Dehydrogenase. Mol.Cancer Ther. (2020)
- Release Date
- 2020-11-04
- Peptides
- Dihydroorotate dehydrogenase (quinone), mitochondrial: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.97 Å
- Oligo State
- monomer
- Ligands
- 1 x R4P: 1-methyl-5-(2'-methyl[1,1'-biphenyl]-4-yl)-1H-benzotriazole-7-carboxylic acid(Non-covalent)
- 2 x DET: UNDECYLAMINE-N,N-DIMETHYL-N-OXIDE(Non-covalent)
- 2 x DDQ: DECYLAMINE-N,N-DIMETHYL-N-OXIDE(Non-covalent)
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- 3 x NA: SODIUM ION(Non-functional Binders)
- 1 x FMN: FLAVIN MONONUCLEOTIDE(Non-covalent)
- 1 x ORO: OROTIC ACID(Non-covalent)
- 3 x ACT: ACETATE ION(Non-functional Binders)
- 6 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- McDonald, G. et al., Selective Vulnerability to Pyrimidine Starvation in Hematologic Malignancies Revealed by AG-636, a Novel Clinical-Stage Inhibitor of Dihydroorotate Dehydrogenase. Mol.Cancer Ther. (2020)
- Release Date
- 2020-11-04
- Peptides
- Dihydroorotate dehydrogenase (quinone), mitochondrial: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A